Poly(ADP-ribose) polymerase-1 could facilitate the religation of topoisomerase I-linked DNA inhibited by camptothecin

Cancer Research

Volumn 65, Issue 9, 2005, Pages 3894-3902

  Park, Shin Young ^a   Cheng, Yung Chi ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

7 ETHYL 10 HYDROXYCAMPTOTHECIN; AMINO ACID; CAMPTOTHECIN; DNA TOPOISOMERASE; N (5,6 DIHYDRO 6 OXO 2 PHENANTHRIDINYL) 2 DIMETHYLAMINOACETAMIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE;

ANIMAL CELL; ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; DRUG SENSITIVITY; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME SUBSTRATE; MOLECULAR INTERACTION; MOLECULAR STABILITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN;

ADENOSINE TRIPHOSPHATE; CAMPTOTHECIN; DNA; DNA TOPOISOMERASES, TYPE I; HUMANS; NAD; OLIGONUCLEOTIDES; PEPTIDE FRAGMENTS; POLY(ADP-RIBOSE) POLYMERASES; RECOMBINANT PROTEINS;

EID: 18144373451     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-04-4014     Document Type: Article

References (38)

1. Wang JC. DNA topoisomerases. Annu Rev Biochem 1996;65:635-92.
2. Wang JC. Cellular roles of DNA topoisomerases: a molecular perspective. Nat Rev Mol Cell Biol 2002;3:430-40.
3. Champoux JJ. DNA topoisomerases: structure, function, and mechanism. Annu Rev Biochem 2001;70:369-413.
4. Pourquier P, Pommier Y. Topoisomerase I-mediated DNA damage. Adv Cancer Res 2001;80:189-216.
5. Liu LE, Desai SD, Li TK, Mao Y, Sun M, Sim SP. Mechanism of action of camptothecin. Ann N Y Acad Sci 2000;922:1-10.
6. Redinbo MR, Stewart L, Kuhn P, Champoux JJ, Hol WG. Crystal structures of human topoisomerase I in covalent and noncovalent complexes with DNA. Science 1998;279:1504-13.
7. Christensen MO, Barthelmes HU, Boege F, Mielke C. The N-terminal domain anchors human topoisomerase I at fibrillar centers of nucleoli and nucleolar organizer regions of mitotic chromosomes. J Biol Chem 2002;277:35932-8.
8. Lisby M, Olesen JR, Skouboe C, et al. Residues within the N-terminal domain of human topoisomerase I play a direct role in relaxation. J Biol Chem 2001;276:20220-7.
9. Frohlich RF, Andersen FF, Westergaard O, Andersen AH, Knudsen BR. Regions within the N-terminal domain of human topoisomerase 1 exert important functions during strand rotation and DNA binding. J Mol Biol 2004;336:93-103.
10. Bharti AK, Olson MO, Kufe DW, Rubin EH. Identification of a nucleolin binding site in human topoisomerase 1. J Biol Chem 1996;271:1993-7.
11. Simmons DT, Melendy T, Usher D, Stillman B. Simian virus 40 large T antigen binds to topoisomerase 1. Virology 1996;222:365-74.
12. Pommier Y, Kohlhagen G, Wu C, Simmons DT. Mammalian DNA topoisomerase I activity and poisoning by camptothecin are inhibited by simian virus 40 large T antigen. Biochemistry 1998;37:3818-23.
13. Mao Y, Mehl IR, Muller MT. Subnuclear distribution of topoisomerase 1 is linked to ongoing transcription and p53 status. Proc Natl Acad Sci U S A 2002;99:235-40.
14. Haluska P Jr, Saleem A, Rasheed Z, et al. Interaction between human topoisomerase I and a novel RING finger/arginine-serine protein. Nucleic Acids Res 1999;27:2538-44.
15. Rallabhandi P, Hashimoto K, Mo YY, Beck WT, Moitra PK, D'Arpa P. Sumoylation of topoisomerase 1 is involved in its partitioning between nucleoli and nucleoplasm and its clearing from nucleoli in response to camptothecin. J Biol Chem 2002;277:40020-6.
16. Mo YY, Wang C, Beck WT. A novel nuclear localization signal in human DNA topoisomerase L. J Biol Chem 2000;275:41107-13.
17. D'Amours D, Desnoyers S, D'Silva I, Poirier GG. Poly(ADP-ribosyl)ation reactions in the regulation of nuclear functions. Biochem J 1999;342:249-68.
18. Burkle A. Physiology and pathophysiology of poly (ADP-ribosyl)ation. Bioessays 2001;23:795-806.
19. Tong WM, Cortes U, Wang ZQ. Poly(ADP-ribose) polymerase: a guardian angel protecting the genome and suppressing tumorigenesis. Biochim Biophys Acta 2001;1552:27-37.
20. Beidler DR, Chang JY, Zhou BS, Cheng YC. Camptothecin resistance involving steps subsequent to the formation of protein-linked DNA breaks in human camptothecin-resistant KB cell lines. Cancer Res 1996;56:345-53.
21. Thompson LH, West MG. XRCC1 keeps DNA from getting stranded. Mutat Res 2000;459:1-18.
22. Vidal AE, Boiteux S, Hickson ID, Radicella JP. XRCC1 coordinates the initial and late stages of DNA abasic site repair through protein-protein interactions. EMBO J 2001;20:6530-9.
23. Whitehouse CJ, Taylor RM, Thistlethwaite A, et al. XRCC1 stimulates human polynucleotide kinase activity at damaged DNA termini and accelerates DNA single-strand break repair. Cell 2001;104:107-17.
24. Chatterjee S, Cheng MF, Trivedi D, Petzold SJ, Berger NA. Camptothecin hypersensitivity in poly(adenosine diphosphate-ribose) polymerase-deficient cell lines. Cancer Commun 1989;1:389-94.
25. Ferro AM, Higgins NP, Olivera BM. Poly(ADP-ribosylation) of a DNA topoisomerase. J Biol Chem 1983;258:6000-3.
26. Ferro AM, Olivera BM. Poly(ADP-ribosylation) of DNA topoisomerase I from calf thymus. J Biol Chem 1984;259:547-54.
27. Bauer PI, Buki KG, Comstock JA, Kun E. Activation of topoisomerase I by poly[ADP-ribose] polymerase. Int J Mol Med 2000;5:533-40.
28. Sastry SS, Kun E. Molecular interactions between DNA, poly(ADP-ribose) polymerase, and histones. J Biol Chem 1988;263:1505-12.
29. Bauer PI, Kun E. Binding of topo I to PARP-1 I-antibody immunocomplex. Int J Mol Med 2000;6:153-4.
30. Bauer PI, Chen HJ, Kenesi E, et al. Molecular interactions between poly(ADP-ribose) polymerase (PARP-1 I) and topoisomerase I (Topo I): identification of topology of binding. FEBS Lett 2001;506:239-42.
31. Malanga M, Althaus FR. Poly(ADP-ribose) reactivates stalled DNA topoisomerase I and induces DNA strand break resealing. J Biol Chem 2004;279:5244-8.
32. Liu SY, Hwang BD, Liu ZC, Cheng YC. Interaction of several nucleoside triphosphate analogues and 10-hydroxycamptothecin with human DNA topoisomerases. Cancer Res 1989;49:1366-70.
33. Chen HJ, Hwang J. Binding of ATP to human DNA topoisomerase 1 resulting in an alteration of the conformation of the enzyme. Eur J Biochem 1999;265:367-75.
34. Rubin E, Pantazis P, Bharti A, Toppmeyer D, Grovanella B, Kute D. Identification of a mutant human topoisomerase I with intact catalytic activity and resistance to 9-nitro-camptothecin. J Biol Chem 1994;269:2433-9.
35. Pleschke JM, Kleczkowska HE, Strohm M, Althaus FR. Poly(ADP-ribose) binds to specific domains in DNA damage checkpoint proteins. J Biol Chem 2000;275:40974-80.
36. Rossi F, Labourier E, Gallouzi IE, et al. The C-terminal domain but not the tyrosine 723 of human DNA topoisomerase I active site contributes to kinase activity. Nucleic Acids Res 1998;26:2963-70.
37. 2+, histones H1 and H3, and ATP. Biochemistry 2004;43:210-6.
38. Ariumi Y, Masutani M, Copeland TD, et al. Suppression of the poly(ADP-ribose) polymerase activity by DNA-dependent protein kinase in vitro. Oncogene 1999;18:4616-25.